市場調查報告書
商品編碼
1463697
北美眼底相機市場預測至 2030 年 - 區域分析 - 按類型、攜帶性、應用和最終用戶North America Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type, Portability, Application, and End User |
2022年北美眼底相機市值為2.6126億美元,預計2030年將達到4.8943億美元;預計2022年至2030年CAGR為8.2%。
糖尿病視網膜病變篩檢程序的增加推動了北美眼底相機市場
糖尿病患者常出現眼科疾病,如角膜異常、青光眼、白內障和神經病變。糖尿病視網膜病變是與該疾病相關的最常見且可能致盲的併發症。這種併發症是美國 25-74 歲族群失明的主要原因。根據 Medscape 報告,美國約有 70 萬人患有增殖性糖尿病視網膜病變,年發生率為 65,000 例。此外,美國40歲以上人口中糖尿病視網膜病變的盛行率高達28.5%。因此,美國人口中糖尿病視網膜病變盛行率的上升加速了對安全、有效和高效的診斷系統(例如眼底照相機)的需求。眼底照相機單元可以是固定的或可攜式的。與眼科診所配備的桌上型設備相比,包括手持式攝影機在內的攜帶式設備以低成本和簡化的操作徹底改變了糖尿病視網膜病變篩檢計畫。然而,桌上型眼底相機可提供良好的影像品質。
北美眼底相機市場概況
眼底攝影有助於檢測和篩檢可治療和可預防的失明的各種原因,特別是 DR、老年黃斑部病變、青光眼和早產兒視網膜病變。根據疾病管制與預防中心的數據,老年性黃斑部病變 (AMD) 是 65 歲及以上美國人失明和視力喪失的主要原因。據 CDC 稱,預計到 2050 年,美國老年人口將從 2015 年的 4800 萬增加到 8800 萬,幾乎加倍。 DR 是糖尿病患者常見的複雜情況。根據國際糖尿病聯盟 (IDF) 的數據,2021 年約有 5.37 億成年人(20-79 歲)患有糖尿病。美國小兒眼科和斜視協會(AAPOS) 的研究(於2023 年4 月更新)分析稱,在美國,每年約有390 萬嬰兒出生時患有早產兒視網膜病變。此外,據估計,其中約有 14,000 人受到這種情況的影響,其中 90% 的人僅患有輕度疾病,近 1,100-1,500 人病情嚴重,需要接受治療。因此,人口中早產兒視網膜病變、DR和老年黃斑部病變的盛行率上升有助於美國眼底相機市場的成長。
北美眼底相機市場營收及 2030 年預測(百萬美元)
北美眼底相機市場區隔
北美眼底相機市場根據類型、攜帶性、應用、最終用戶和國家進行細分。
根據類型,北美眼底相機市場分為散瞳眼底相機、免散瞳眼底相機、混合眼底相機和ROP眼底相機。免散瞳眼底相機細分市場在 2022 年佔據最大市場。
基於攜帶性,北美眼底相機市場分為手持式和桌上型。 2022 年,桌面細分市場佔據了更大的市場。
根據應用,北美眼底相機市場分為糖尿病性視網膜病變、老年黃斑部病變、視網膜血管疾病等。 2022 年,糖尿病視網膜病變細分市場佔最大市場。
根據最終用戶,北美眼底相機市場分為醫院、眼科中心等。 2022 年,醫院細分市場佔據最大市場佔有率。
按國家/地區分類,北美眼底相機市場分為美國、加拿大和墨西哥。 2022年,美國在北美眼底相機市場佔有率中佔據主導地位。
Nikon Corp、Topcon Corp、NIDEK CO LTD、Canon Inc、Carl Zeiss AG、Visionix USA Inc、Kowa Co Ltd 和 Volk Optical Inc 是北美眼底相機市場的一些領先廠商。
表中的內容
The North America fundus cameras market was valued at US$ 261.26 million in 2022 and is expected to reach US$ 489.43 million by 2030; it is estimated to grow at a CAGR of 8.2% from 2022 to 2030.
Increase in Diabetic Retinopathy Screening Procedures Fuel the North America Fundus Cameras Market
Patients who have diabetes often develop ophthalmic conditions such as corneal abnormalities, glaucoma, cataracts, and neuropathies. Diabetic retinopathy has been the most common and potentially blinding complication associated with the disease. This complication is a leading cause of blindness among persons aged 25-74 years in the US. As per the Medscape report, ~700,000 persons in the US suffer from proliferative diabetic retinopathy with an annual incidence of 65,000. Moreover, the prevalence of diabetic retinopathy in the US accounts for 28.5% among people aged 40 or older. Thus, the rising prevalence of diabetic retinopathy among the US population accelerates demand for safe, effective, and efficient diagnostic systems, such as fundus cameras. The fundus camera units can be fixed or portable. Portable units, including handheld cameras, have revolutionized diabetic retinopathy screening programs with low costs and simplified operations, compare to desktop ones equipped in ophthalmology clinics. However, desktop fundus cameras provide good image quality.
North America Fundus Cameras Market Overview
Fundus photography is instrumental in the detection and screening of various causes of treatable and preventable blindness, notably DR, age-related macular degeneration, glaucoma, and retinopathy of prematurity. According to the Centers for Disease Control and Prevention, age-related macular degeneration (AMD) is a leading cause of blindness and vision loss among Americans aged 65 and more. According to CDC, the geriatric population in the US is anticipated to nearly double from 48 million in 2015 to 88 million in 2050. Nearly 20 million adults in the US face some form of age-related macular degeneration. DR is a commonly seen complexity in diabetic patients. According to the International Diabetes Federation (IDF), ~537 million adults (20-79 years of age) were living with diabetes in 2021. The same source also reported that the total number of people living with diabetes is estimated to rise to 643 million by 2030. Further, the study (updated in April 2023) by the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) analyzed that annually in the US, ~3.9 million infants are born with retinopathy of prematurity. Moreover, ~14,000 of these are estimated to be affected by this condition and 90% of those affected have only mild disease, and nearly 1,100- 1,500 develop disease severe enough to require medical treatment. Therefore, such a rise in the prevalence of retinopathy of prematurity, DR, and age-related macular degeneration in the population contributes to the US fundus camera market growth in the US.
North America Fundus Cameras Market Revenue and Forecast to 2030 (US$ Million)
North America Fundus Cameras Market Segmentation
The North America fundus cameras market is segmented based on type, portability, application, end user, and country.
Based on type, the North America fundus cameras market is segmented into mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022.
Based on portability, the North America fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment held a larger market share in 2022.
Based on application, the North America fundus cameras market is segmented into diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment held the largest market share in 2022.
Based on end user, the North America fundus cameras market is segmented into hospitals, ophthalmology centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the North America fundus cameras market is segmented into the US, Canada, and Mexico. The US dominated the North America fundus cameras market share in 2022.
Nikon Corp, Topcon Corp, NIDEK CO LTD, Canon Inc, Carl Zeiss AG, Visionix USA Inc, Kowa Co Ltd, and Volk Optical Inc are some of the leading players operating in the North America fundus cameras market.
Table of Content